Social media in the pharmaceutical sector

A recent survey by Accenture of sales and marketing executives at large pharmaceutical companies, called ‘Life in the New Normal: The Customer Engagement Revolution’, shows that one in four interactions with doctors, healthcare providers and patients in the US is now digital. This is expected to increase by at least 26 per cent in the next two years and the benefits are clear — highly focused marketing, increased geographical reach, greater customer engagement and reduced marketing costs being just some examples.

While other industries have immersed themselves in the use of new technologies and marketing channels to promote their products, the pharmaceutical industry has taken a far more cautious approach. One reason for this is that the industry is highly regulated, meaning that some of the attractions of social media — greater customer interaction and two-way communication — bring with them certain risks, such as patient confidentiality issues, off-label promotion and the possibility of triggering reporting obligations under pharmacovigilance regulations…

If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.

Sign in or Register to continue reading this article

Sign in

Register

It's quick, easy and free!

It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.

Register now

Why register to The Lawyer

 

Industry insight

In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.

 

Market intelligence

Identify the major players and business opportunities within a particular region through our series of free, special reports.

 

Email newsletters

Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.

More relevant to you

To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.

Briefings from Taylor Wessing

View more briefings from Taylor Wessing

Analysis from The Lawyer

  • merger deal

    Corporate crunch time: who will triumph at The Lawyer Awards 2014?

    As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014. 

  • singapore orchid

    Singapore: Cash course

    The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world

View more analysis from The Lawyer

Overview

5 New Street Square
London
EC4A 3TW
UK
http://www.taylorwessing.com

Turnover (£m): 241.20
No. of lawyers: 860 (UK 200)
Jurisdiction: UK
No. of offices: 6
No. of qualified lawyers: 73 (International 50)
No. of partners: 29